Coronavirus Education

The antimalarial drug, Plaquenil aka hydroxychloroquine is shown to stop the coronavirus replication in culture and now in humans. Dr. Lewis discusses all aspects of this drug; safety, efficacy, history, and cutting-edge results on it effect on SARS-CoV-2 – The Coronavirus – COVID-19. The latest results from France, which involve 80 patients, were reported on March 27. The investigators reported a significant reduction in the viral load (83% patients had negative results at day 7, and 93% had negative results on day 8). There was a “clinical improvement compared to the natural progression” on hydroxychloroquine and azithromycin. One death occurred, and three patients were transferred to intensive care units. Thus, this drug is not 100% effective, and further study is still required. It is still unclear how the chloroquines (or any antimalarial drug) would work against COVID-19, which is a virus. Malaria is caused by Plasmodium parasites that are spread by mosquitoes, whereas COVID-19 is caused by the SARS-CoV-2 virus.

The antimalarial drug, Plaquenil aka hydroxychloroquine is shown to stop the coronavirus replication in culture and now in humans. Dr. Lewis discusses all aspects of this drug; safety, efficacy, history, and cutting-edge results on it effect on SARS-CoV-2 – The Coronavirus – COVID-19. The latest results from France, which involve 80 patients, were reported on March 27. The investigators reported a significant reduction in the viral load (83% patients had negative results at day 7, and 93% had negative results on day 8). There was a “clinical improvement compared to the natural progression” on hydroxychloroquine and azithromycin. One death occurred, and three patients were transferred to intensive care units. Thus, this drug is not 100% effective, and further study is still required. It is still unclear how the chloroquines (or any antimalarial drug) would work against COVID-19, which is a virus. Malaria is caused by Plasmodium parasites that are spread by mosquitoes, whereas COVID-19 is caused by the SARS-CoV-2 virus.

COVID-19 strikes the weak and sick most profoundly. Are you immunocompromised? How immunocompromised are you? How do you find out quickly and make changes to improve your immune system status. Dr. Lewis discusses the definition of immunocompromised. For example, people with cardiovascular disease die at 12 times the rate compared to healthy people. The conundrum is that half the U.S. population has heart disease but many are not aware or diagnosed (American Heart Association). One in four people with diabetes doesn’t know it (American Diabetes Association). “Ill-defined” conditions, not cardiovascular disease, if the most prevalent and costly disease in America (Peterson Kaiser report). Paragraph Being immunocompromised is the common denominator behind all chronic diseases. What does this mean to you? You have substantial risk of dying or having very severe symptoms from the SARS-CoV-2 virus because, of high probability, you are immunocompromised. Paragraph Dr. Lewis, medical scientist, discusses your risk of dying from COVID-19 based on pre-existing conditions and your “immunocompromised” status. He points you to a risk survey his Harvard and MIT team developed that helps you understand your immune system health status and what your can do to improve your resistance to COVID-19.

COVID-19 strikes the weak and sick most profoundly. Are you immunocompromised? How immunocompromised are you? How do you find out quickly and make changes to improve your immune system status. Dr. Lewis discusses the definition of immunocompromised. For example, people with cardiovascular disease die at 12 times the rate compared to healthy people. The conundrum is that half the U.S. population has heart disease but many are not aware or diagnosed (American Heart Association). One in four people with diabetes doesn’t know it (American Diabetes Association). “Ill-defined” conditions, not cardiovascular disease, if the most prevalent and costly disease in America (Peterson Kaiser report). Paragraph Being immunocompromised is the common denominator behind all chronic diseases. What does this mean to you? You have substantial risk of dying or having very severe symptoms from the SARS-CoV-2 virus because, of high probability, you are immunocompromised. Paragraph Dr. Lewis, medical scientist, discusses your risk of dying from COVID-19 based on pre-existing conditions and your “immunocompromised” status. He points you to a risk survey his Harvard and MIT team developed that helps you understand your immune system health status and what your can do to improve your resistance to COVID-19.

According to Dr. Lewis, initially, a small percentage of the population with be tested for the coronavirus, SARS-CoV-2. Yet everyone can be tested for their risk of severe symptoms. People with chronic conditions and immunocompromised people die from COVID-19 at rates up to 1200% higher compared to healthy people. Dr. Lewis discusses testing that established how “immunocompromised” you are and then gives solutions to increase your odds against severe symptoms or dying from COVID-19. Paragraph The concept of immunocompromised status is not well defined but much discussed since the pandemic of COVID-19 disease. Harvard Medical School, at their hospital, Mass General, risk stratifies people who are hospitalized and test positive for the novel coronavirus. They do this to determine appropriate case urgency. The blood tests that Dr. Lewis and his team developed are similar yet more comprehensive compared to those performed by Harvard. Importantly, Dr. Lewis’ tests are available to anyone while those at Mass General are only for people already hospitalized with COVID-19

According to Dr. Lewis, initially, a small percentage of the population with be tested for the coronavirus, SARS-CoV-2. Yet everyone can be tested for their risk of severe symptoms. People with chronic conditions and immunocompromised people die from COVID-19 at rates up to 1200% higher compared to healthy people. Dr. Lewis discusses testing that established how “immunocompromised” you are and then gives solutions to increase your odds against severe symptoms or dying from COVID-19. Paragraph The concept of immunocompromised status is not well defined but much discussed since the pandemic of COVID-19 disease. Harvard Medical School, at their hospital, Mass General, risk stratifies people who are hospitalized and test positive for the novel coronavirus. They do this to determine appropriate case urgency. The blood tests that Dr. Lewis and his team developed are similar yet more comprehensive compared to those performed by Harvard. Importantly, Dr. Lewis’ tests are available to anyone while those at Mass General are only for people already hospitalized with COVID-19

Remdesivir is proven to reverse, stop, or cure COVID-19 in initial trials. However, the number of people treated is not sufficient to draw a conclusion on how well the drug will work generally. Remdesivir kills the COVID-19 virus, SARS-CoV-2 (novel coronavirus) by stopping replication of the virus. Remdesivir is a broad-spectrum antiviral agent. It was developed as a treatment for Ebola virus infection. It causes a decrease in viral RNA production, thus limiting replication and proliferation of the infection. Initial results from three U.S. COVID-19 patients who were treated with Remdesivir outside of a clinical trial are not uniformly successful. Here is information about a case study presented by Dr. Lewis. According to MYNorthwest News, “His dad was sick at home for a few days before his oxygen levels dropped, forcing him to go to the hospital, where he tested positive for coronavirus. He was also suffering from pneumonia. His doctor gave his father Remdesivir, a drug originally intended to treat Ebola that’s seen some success in a handful of isolated coronavirus cases. The treatment dropped his fever quickly and he steadily improved. Now, nine days after going to the emergency room, his dad is going home.

Remdesivir is proven to reverse, stop, or cure COVID-19 in initial trials. However, the number of people treated is not sufficient to draw a conclusion on how well the drug will work generally. Remdesivir kills the COVID-19 virus, SARS-CoV-2 (novel coronavirus) by stopping replication of the virus. Remdesivir is a broad-spectrum antiviral agent. It was developed as a treatment for Ebola virus infection. It causes a decrease in viral RNA production, thus limiting replication and proliferation of the infection. Initial results from three U.S. COVID-19 patients who were treated with Remdesivir outside of a clinical trial are not uniformly successful. Here is information about a case study presented by Dr. Lewis. According to MYNorthwest News, “His dad was sick at home for a few days before his oxygen levels dropped, forcing him to go to the hospital, where he tested positive for coronavirus. He was also suffering from pneumonia. His doctor gave his father Remdesivir, a drug originally intended to treat Ebola that’s seen some success in a handful of isolated coronavirus cases. The treatment dropped his fever quickly and he steadily improved. Now, nine days after going to the emergency room, his dad is going home.

Dr. Lewis discusses how viruses are part of our world and are often linked to chronic diseases and disability by the medical research community but not by doctors who treat patients. He discusses the U.S. healthcare system, SARS-CoV-2 Infection, COVID-19, coronavirus and also examines other viruses and their impact on human health. He also shows case studies of positive outcomes when infections are diagnosed and treated as causal agents. Paragraph Viruses, in our modern healthcare system, are assumed to cause “acute” or sudden illness, like COVID-19. Viruses cause familiar infectious diseases such as the common cold, flu and warts. They also cause severe illnesses such as HIV/AIDS, smallpox, and Ebola. However, they also cause chronic conditions that the current healthcare system “manages” with drugs, rather than finding the cause and curing them. Here is a short list of common chronic diseases that have many peer-reviewed and evidence-based publications showing a connection between the disease and viruses: Cardiovascular disease – 1.3 million references; Cancer – 3.0 million references; Alzheimer’s – 185,000 references; diabetes – 2.2 million references; and autoimmune diseases – 1.3 million references. Paragraph Dr. Lewis presents several case studies on people with severe diseases who were cured by treating underlying infection including viruses.

Dr. Lewis discusses how viruses are part of our world and are often linked to chronic diseases and disability by the medical research community but not by doctors who treat patients. He discusses the U.S. healthcare system, SARS-CoV-2 Infection, COVID-19, coronavirus and also examines other viruses and their impact on human health. He also shows case studies of positive outcomes when infections are diagnosed and treated as causal agents. Paragraph Viruses, in our modern healthcare system, are assumed to cause “acute” or sudden illness, like COVID-19. Viruses cause familiar infectious diseases such as the common cold, flu and warts. They also cause severe illnesses such as HIV/AIDS, smallpox, and Ebola. However, they also cause chronic conditions that the current healthcare system “manages” with drugs, rather than finding the cause and curing them. Here is a short list of common chronic diseases that have many peer-reviewed and evidence-based publications showing a connection between the disease and viruses: Cardiovascular disease – 1.3 million references; Cancer – 3.0 million references; Alzheimer’s – 185,000 references; diabetes – 2.2 million references; and autoimmune diseases – 1.3 million references. Paragraph Dr. Lewis presents several case studies on people with severe diseases who were cured by treating underlying infection including viruses.

The coronavirus, SARS-CoV-2, is found in the gut of ~50% of the people with the disease, experts estimate based on initial testing. Importantly, the virus is detected in stool samples even when saliva samples are NEGATIVE, at least based on early report. The novel coronavirus (2019-nCoV) shows evidence of causing gastrointestinal symptoms and has the potential to be transmitted by the fecal-oral route. Paragraph In a study of hospitalized patients in Wuhan, China, 10.1% of coronavirus patients had diarrhea and nausea in the 1-2 days before onset of fever and dyspnea. The first U.S. patient to be diagnosed had a 2-day history of nausea and vomiting, and had a loose bowel movement on the second day in the hospital. Clinicians later confirmed the presence of viral RNA in both the patient’s stool and airway. Paragraph Dr. Carter a board-certified physician with over 10 years of expanded education into functional or root-cause medicine, discusses the COVID-19 gut connection and what you can do to improve your gut health and potentially stop the virus from spreading through your body by way of the gut.

The coronavirus, SARS-CoV-2, is found in the gut of ~50% of the people with the disease, experts estimate based on initial testing. Importantly, the virus is detected in stool samples even when saliva samples are NEGATIVE, at least based on early report. The novel coronavirus (2019-nCoV) shows evidence of causing gastrointestinal symptoms and has the potential to be transmitted by the fecal-oral route. Paragraph In a study of hospitalized patients in Wuhan, China, 10.1% of coronavirus patients had diarrhea and nausea in the 1-2 days before onset of fever and dyspnea. The first U.S. patient to be diagnosed had a 2-day history of nausea and vomiting, and had a loose bowel movement on the second day in the hospital. Clinicians later confirmed the presence of viral RNA in both the patient’s stool and airway. Paragraph Dr. Carter a board-certified physician with over 10 years of expanded education into functional or root-cause medicine, discusses the COVID-19 gut connection and what you can do to improve your gut health and potentially stop the virus from spreading through your body by way of the gut.

Dr. Carter is a board-certified physician. Over the past 10 years, Dr. Carter has expanded his education into functional or root-cause medicine, initially driven by a personal struggle with glaucoma. He has obtained an impressive amount of continuing educational certifications in topics including: stem cells, energy medicine, nutrition, advanced peptides, cancer treatment, and solutions to Alzheimer’s disease. Dr. Lewis holds a Ph.D. from MIT and continuing education from the Harvard School of Public Health. Since his dad came down with Alzheimer’s 20 years ago, he has dedicated his life to determining how to better predict Alzheimer’s and chronic diseases in general. Paragraph They hone in on how certain pharmaceutical drugs actually may make a person more susceptible to COVID-19 and increase the risk of dying from the disease. In particular, certain blood pressure medications biologic drugs, anti-inflammatory drugs, gut acid suppressing drugs and cholesterol lowering may make COVID-19 worse, or even fatal. You need a strong immune system to fight the SARS-CoV-2 virus. Many common prescription medications “manage” disease symptoms. Most of these drugs manage symptoms by suppressing your immune response. You often feel better on these pharmaceuticals but you are also made more vulnerable to severe disease like COVID-19.

Dr. Carter is a board-certified physician. Over the past 10 years, Dr. Carter has expanded his education into functional or root-cause medicine, initially driven by a personal struggle with glaucoma. He has obtained an impressive amount of continuing educational certifications in topics including: stem cells, energy medicine, nutrition, advanced peptides, cancer treatment, and solutions to Alzheimer’s disease. Dr. Lewis holds a Ph.D. from MIT and continuing education from the Harvard School of Public Health. Since his dad came down with Alzheimer’s 20 years ago, he has dedicated his life to determining how to better predict Alzheimer’s and chronic diseases in general. Paragraph They hone in on how certain pharmaceutical drugs actually may make a person more susceptible to COVID-19 and increase the risk of dying from the disease. In particular, certain blood pressure medications biologic drugs, anti-inflammatory drugs, gut acid suppressing drugs and cholesterol lowering may make COVID-19 worse, or even fatal. You need a strong immune system to fight the SARS-CoV-2 virus. Many common prescription medications “manage” disease symptoms. Most of these drugs manage symptoms by suppressing your immune response. You often feel better on these pharmaceuticals but you are also made more vulnerable to severe disease like COVID-19.

Dr. Michael Carter, MD and functional medicine practitioner explains what a virus is, what is unique about SARS-CoV-2, the virus that causes the disease COVID-19. He also explains how to tell if you have the cold, flu, or COVID-19 and he explains a surprising meaning of immunocompromised. Paragraph Dr. Carter is a board-certified physician. Over the past 10 years, Dr. Carter has expanded his education into functional or root-cause medicine, initially driven by a personal struggle with glaucoma. He has obtained an impressive amount of continuing educational certifications in topics including: stem cells, energy medicine, nutrition, advanced peptides, cancer treatment, and solutions to Alzheimer’s disease. Dr. Carter runs a successful virtual health center where he offers a deep diagnostic dive into the root-cause of complex and often ill-defined health conditions. His research had led to non-pharmaceutical interventions and protocols the provide his patients with lasting and sustainable resolution from their pre-existing chronic health maladies. Dr. Carter is co-inventor of the 4-Dimensions of Health program that identifies risk and causes of disease at the root-cause and maps the information to a personalized and precision care plan that very often completely reverses (cures) and individual’s disease.